Follow
Dan G. Duda, DMD, PhD
Dan G. Duda, DMD, PhD
Professor of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School
Verified email at partners.org - Homepage
Title
Cited by
Cited by
Year
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
CG Willett, Y Boucher, E Di Tomaso, DG Duda, LL Munn, RT Tong, ...
Nature medicine 10 (2), 145-147, 2004
25062004
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
TT Batchelor, AG Sorensen, E di Tomaso, WT Zhang, DG Duda, ...
Cancer cell 11 (1), 83-95, 2007
20922007
Normalization of the vasculature for treatment of cancer and other diseases
S Goel, DG Duda, L Xu, LL Munn, Y Boucher, D Fukumura, RK Jain
Physiological reviews 91 (3), 1071-1121, 2011
17022011
Angiogenesis in brain tumours
RK Jain, E Di Tomaso, DG Duda, JS Loeffler, AG Sorensen, TT Batchelor
Nature Reviews Neuroscience 8 (8), 610-622, 2007
16032007
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
D Fukumura, J Kloepper, Z Amoozgar, DG Duda, RK Jain
Nature reviews Clinical oncology 15 (5), 325-340, 2018
14622018
Lessons from phase III clinical trials on anti-VEGF therapy for cancer
RK Jain, DG Duda, JW Clark, JS Loeffler
Nature clinical practice Oncology 3 (1), 24-40, 2006
13802006
Engineering vascularized tissue
RK Jain, P Au, J Tam, DG Duda, D Fukumura
Nature biotechnology 23 (7), 821-823, 2005
9972005
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
Y Huang, J Yuan, E Righi, WS Kamoun, M Ancukiewicz, J Nezivar, ...
Proceedings of the National Academy of Sciences 109 (43), 17561-17566, 2012
9582012
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
D Pfister, NG Nez, R Pinyol, O Govaere, M Pinter, M Szydlowska, ...
Nature 592 (7854), 450-456, 2021
8172021
Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma
A Jusakul, I Cutcutache, CH Yong, JQ Lim, MN Huang, N Padmanabhan, ...
Cancer discovery 7 (10), 1116-1135, 2017
7382017
Vascular normalization as an emerging strategy to enhance cancer immunotherapy
Y Huang, S Goel, DG Duda, D Fukumura, RK Jain
Cancer research 73 (10), 2943-2948, 2013
6462013
Malignant cells facilitate lung metastasis by bringing their own soil
DG Duda, AMMJ Duyverman, M Kohno, M Snuderl, EJA Steller, ...
Proceedings of the National Academy of Sciences 107 (50), 21677-21682, 2010
6462010
Biomarkers of response and resistance to antiangiogenic therapy
RK Jain, DG Duda, CG Willett, DV Sahani, AX Zhu, JS Loeffler, ...
Nature reviews Clinical oncology 6 (6), 327-338, 2009
6462009
Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?
RR Ramjiawan, AW Griffioen, DG Duda
Angiogenesis 20, 185-204, 2017
6162017
HCC and angiogenesis: possible targets and future directions
AX Zhu, DG Duda, DV Sahani, RK Jain
Nature reviews Clinical oncology 8 (5), 292-301, 2011
5862011
Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study
CG Willett, DG Duda, E Di Tomaso, Y Boucher, M Ancukiewicz, ...
Journal of Clinical Oncology 27 (18), 3020, 2009
5842009
Phase II study of cediranib, an oral pan–vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma
TT Batchelor, DG Duda, E di Tomaso, M Ancukiewicz, SR Plotkin, ...
Journal of Clinical Oncology 28 (17), 2817, 2010
5672010
Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo
M Stroh, JP Zimmer, DG Duda, TS Levchenko, KS Cohen, EB Brown, ...
Nature medicine 11 (6), 678-682, 2005
5612005
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study
AX Zhu, DV Sahani, DG Duda, E di Tomaso, M Ancukiewicz, OA Catalano, ...
Journal of clinical oncology 27 (18), 3027, 2009
5492009
Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre‐clinical models
DAI Fukumura, DG Duda, LL Munn, RK Jain
Microcirculation 17 (3), 206-225, 2010
5272010
The system can't perform the operation now. Try again later.
Articles 1–20